Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma.
about
Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic miceAn Epstein-Barr virus protein interacts with NotchCytokine and immunoglobulin production by PWM-stimulated peripheral and tumor-infiltrating lymphocytes of undifferentiated nasopharyngeal carcinoma (NPC) patientsUnderstanding the interplay between host immunity and Epstein-Barr virus in NPC patientsHLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of {beta}-catenin signalingThe Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitiveEstablishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID miceEpithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase.Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63alpha expression is associated with impaired epithelial-cell differentiationEpstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis.Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase.Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line.Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray.Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia.Structural analyses of the Epstein-Barr virus BamHI A transcriptsThe Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor.The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-Less promoter within the first terminal repeat.5' Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio.Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals.Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.The role of miRNAs and EBV BARTs in NPC.Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cellsEpstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through αv-integrin membrane translocation.Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins.Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes.Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B.Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.Mutants of Epstein-Barr virus with a selective marker disrupting the TP gene transform B cells and replicate normally in culture.The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus.Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing.Potential selection of LMP1 variants in nasopharyngeal carcinoma.
P2860
Q24524255-B931E72D-0AAA-489C-8CEC-5C8C345EDB49Q24529019-0DF10EB5-0ADE-45DA-AAB8-8D6B75936862Q24800020-14EFB230-AC2C-4846-A13E-52A1E34A6810Q26823898-F170B4D8-4A93-4DE4-A398-EC0AB40CBA19Q30452144-43DE0A00-2441-4224-835C-4B4EC510AB92Q33598586-3DD4BC99-09F4-4D9B-9698-34E8D51A1187Q33781678-3A584D37-16D0-41F2-B608-EDD12D1CF1FAQ33783746-15B4FE31-F87A-429B-9AC9-2A0350C659BAQ33784983-3B18884B-1B6E-4F9E-8C5F-E7AD3577C073Q33813796-459ED236-6DBD-4065-A424-566AD2ADD48FQ34029669-A373EFF9-0C5A-49E6-8B39-2C86F9E301BDQ34228703-56EA78CE-A712-4E5C-BFF2-321FE0F4BD32Q34344427-51DA3E31-2CE9-46C4-ACA3-004B7674B696Q34502958-876A6ACF-2575-4994-BB2F-FC401B75D76CQ35463816-DFC244AF-01CC-4B88-A08A-DA782E91EBF8Q35798133-DE16E35C-B00A-4613-AD62-F07CB877D8B4Q35832657-6221DCD7-C149-4079-8A37-E4EE3FA2D210Q35841701-CB418B15-105E-48BB-B6E1-F3F230B7B428Q35842451-F8D5EE7C-54F7-4C37-9ED0-CB02B5D0E243Q35852557-9EE6111F-7E8F-485E-BCBC-67F8798D85D9Q35865472-9961C2B7-56CF-4A01-AB65-AC451BC55258Q35873657-2656F7C8-888E-4998-A914-6139CF16082BQ35875444-88DB1E20-FD30-451C-8208-E875E0E0DCFAQ35924359-F7C4FAF0-8EB6-4728-BD59-0708275CE7AFQ36086653-92CCE5E4-D50A-49F5-9AEC-D5766A849B58Q36135900-604B9A9A-9455-48F1-9040-4A8B03851C86Q36276627-51877D86-B2AF-41DE-B120-98E0EA8565BCQ36628637-860AC980-89EE-47B4-9867-EB7942E76323Q36637195-D69EE501-D5C4-4A6A-8270-F568ADEF6DA1Q36646940-460C9E7E-C5F0-4311-8C02-4F9B546CB9EAQ36651589-564EFD65-F4C4-45D8-9333-E67EE265609DQ36653989-8C96DE35-C8F8-490D-8EB9-4F48CBEC6C8DQ36655549-576487A1-8E47-4FE7-9628-DE53FF887AE2Q36685081-743A776A-79BD-4687-A16F-967926B3F07FQ36686042-BB48D33D-85A9-4628-83E7-1935243293A4Q36687455-B30726A1-4CFC-40A7-BD64-F1379093CDD6Q36849568-DD22F9F2-C470-4D7D-AFF3-8F59AF371A32Q36890676-BFBC9A2B-A35D-4968-B178-2D8CA93EFC39Q36898733-18ED3BFF-0EB1-4E93-AC78-68BAE3005260Q36944141-6DE8C65B-7ECA-4047-A02B-6D37668A424B
P2860
Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma.
@ast
Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma.
@en
type
label
Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma.
@ast
Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma.
@en
prefLabel
Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma.
@ast
Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma.
@en
P2093
P2860
P1433
P1476
Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma
@en
P2093
P2860
P304
P407
P577
1992-05-01T00:00:00Z